AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 MAY 7 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline (GSK) will award $500,000 in grants for innovative HIV/AIDS drug research in recognition of the need to produce new alternatives and hope in the fight against the HIV/AIDS pandemic.
Applications are now being solicited for 2003 research grants and must be submitted by July 31. The one-time research grants range from $25,000 to $150,000 and are intended to further the development of inventive treatments for HIV/AIDS, including therapies aimed at treating infection, prophylactic vaccines, or microbicides designed to prevent transmission of the virus.
"It has been gratifying to fund such innovative research and to recognize researchers - here and internationally - of this caliber," said Doug Manion, MD, vice president of clinical development for GSK. "We've been very pleased with the diversity of the projects submitted, which have ranged from research on protein recognition to the molecular virology of HIV integration, and believe the grants provide us with a way to demonstrate our commitment to scientific research investigating the mysteries of HIV and AIDS."
Since the inception of the Drug Discovery and Development Research Grant Program in 2001, GSK has honored nine researchers for their groundbreaking work toward new pharmaceutical strategies to combat the HIV ...
Source: HighBeam Research, Drug discovery, development research grant program announced.